Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.
2025
Q2 2025
Quarter Ended Sep 30, 2024
Q1 2025
Quarter Ended Jun 30, 2024
2024
2023
FY 2023
Fiscal Year Ended Mar 31, 2023
Q3 2023
Quarter Ended Dec 31, 2022
Q2 2023
Quarter Ended Sep 30, 2022
Q1 2023
Quarter Ended Jun 30, 2022
2022
FY 2022
Fiscal Year Ended Mar 31, 2022
Q3 2022
Quarter Ended Dec 31, 2021
Q2 2022
Quarter Ended Sep 30, 2021
Q1 2022
Quarter Ended Jun 30, 2021
2021
FY 2021
Fiscal Year Ended Mar 31, 2021
Q3 2021
Quarter Ended Dec 31, 2020
Q2 2021
Quarter Ended Sep 30, 2020
Q1 2021
Quarter Ended Jun 30, 2020
2020
FY 2020
Fiscal Year Ended Mar 31, 2020
Q3 2020
Quarter Ended Dec 31, 2019
Q2 2020
Quarter Ended Sep 30, 2019
Q1 2020
Quarter Ended Jun 30, 2019
2019
FY 2019
Fiscal Year Ended Mar 31, 2019
Q3 2019
Quarter Ended Dec 31, 2018
Q2 2019
Quarter Ended Sep 30, 2018
Q1 2019
Quarter Ended Jun 30, 2018
2018
FY 2018
Fiscal Year Ended Mar 31, 2018
Q3 2018
Quarter Ended Dec 31, 2017
Q2 2018
Quarter Ended Sep 30, 2017
Q1 2018
Quarter Ended Jun 30, 2017
2017
FY 2017
Fiscal Year Ended Mar 31, 2017
Q3 2017
Quarter Ended Dec 31, 2016
Q2 2017
Quarter Ended Sep 30, 2016
Q1 2017
Quarter Ended Jun 30, 2016
2016
FY 2016
Fiscal Year Ended Mar 31, 2016
Q3 2016
Quarter Ended Dec 31, 2015
Q2 2016
Quarter Ended Sep 30, 2015
Q1 2016
Quarter Ended Jun 30, 2015